Citi lowered the firm’s price target on Albertsons (ACI) to $22 from $26 and keeps a Buy rating on the shares. The company’s Q4 comps missed consensus but the stock’s risk/reward is favorable, the analyst tells investors in a research note. Citi says Albertsons’ pharmacy pricing pressured sales.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACI:
- Albertsons Earnings Call: AI, Cash Returns Offset Headwinds
- Midday Fly By: Amazon to buy Globalstar, J&J posts ‘beat and raise’ report
- Albertsons Announces Opioid Settlement Framework and Outlook
- Albertsons board raises quarterly dividend to 17c per share
- Albertsons reachs $774M national opioid settlement framework